色素-话题@MedSci

#色素#

654篇内容 | 6197人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680692, encodeId=b08a168069232, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JCO：CheckMate 066试验| 纳武单抗治疗晚期黑色素瘤的5年随访结果, objectType=article, longId=201677, objectId=01c02016e7b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01c02016e7b3, replyNumber=0, likeNumber=61, createdTime=2020-11-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01c02016e7b3, moduleTitle=JCO：CheckMate 066试验| 纳武单抗治疗晚期黑色素瘤的5年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01c02016e7b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680685, encodeId=9d7f168068503, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clinica Chimica Acta：色素试纸:一种排除蛛网膜下腔出血的快速试验, objectType=article, longId=199071, objectId=f0691990e1d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0691990e1d1, replyNumber=0, likeNumber=69, createdTime=2021-04-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0691990e1d1, moduleTitle=Clinica Chimica Acta：色素试纸:一种排除蛛网膜下腔出血的快速试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0691990e1d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680683, encodeId=45c7168068309, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=肺原发黑色素瘤一例, objectType=article, longId=198935, objectId=288a1989355d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288a1989355d, replyNumber=0, likeNumber=63, createdTime=2021-04-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288a1989355d, moduleTitle=肺原发黑色素瘤一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=288a1989355d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680678, encodeId=804d16806e8ba, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：粘膜和手指黑色素瘤转移-病例报道, objectType=article, longId=197278, objectId=aa2e19e27840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2e19e27840, replyNumber=0, likeNumber=55, createdTime=2021-01-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2e19e27840, moduleTitle=NEJM：粘膜和手指黑色素瘤转移-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2e19e27840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680691, encodeId=212716806915a, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=人各有“痣”：痣出现这些变化，有恶变的可能！黑色素瘤不能小看, objectType=article, longId=201510, objectId=54252015102c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54252015102c, replyNumber=0, likeNumber=73, createdTime=2021-07-17, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54252015102c, moduleTitle=人各有“痣”：痣出现这些变化，有恶变的可能！黑色素瘤不能小看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54252015102c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680670, encodeId=c0ae16806e0d3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=腹透液检查竟发现恶性黑色素瘤细胞！, objectType=article, longId=194470, objectId=3fef1944e0fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fef1944e0fb, replyNumber=0, likeNumber=69, createdTime=2020-07-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fef1944e0fb, moduleTitle=腹透液检查竟发现恶性黑色素瘤细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fef1944e0fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680649, encodeId=904316806492d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=罗氏的PD-L1单抗Tecentriq组合显着降低黑色素瘤患者的疾病进展和死亡风险, objectType=article, longId=184877, objectId=fe901848e7f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe901848e7f2, replyNumber=0, likeNumber=65, createdTime=2020-05-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe901848e7f2, moduleTitle=罗氏的PD-L1单抗Tecentriq组合显着降低黑色素瘤患者的疾病进展和死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe901848e7f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680671, encodeId=328616806e1d0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, objectType=article, longId=194493, objectId=0f2419449384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2419449384, replyNumber=0, likeNumber=103, createdTime=2021-04-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2419449384, moduleTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2419449384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680664, encodeId=7ad6168066469, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Death Dis：HopQ通过降解波形蛋白抑制黑色素瘤迁移, objectType=article, longId=192721, objectId=bc96192e21d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc96192e21d9, replyNumber=0, likeNumber=73, createdTime=2020-09-30, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc96192e21d9, moduleTitle=Cell Death Dis：HopQ通过降解波形蛋白抑制黑色素瘤迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc96192e21d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680666, encodeId=a91516806665e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, objectType=article, longId=193346, objectId=688d193346bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688d193346bb, replyNumber=0, likeNumber=124, createdTime=2021-01-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688d193346bb, moduleTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=688d193346bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680675, encodeId=b95516806e5c5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, objectType=article, longId=196199, objectId=04db19619962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04db19619962, replyNumber=0, likeNumber=92, createdTime=2020-09-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04db19619962, moduleTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04db19619962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680679, encodeId=738a16806e9bb, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=色素性单纯性汗腺棘皮瘤1例, objectType=article, longId=197439, objectId=a0b819e43976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b819e43976, replyNumber=0, likeNumber=74, createdTime=2020-10-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b819e43976, moduleTitle=色素性单纯性汗腺棘皮瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0b819e43976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680662, encodeId=8c6e168066217, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=神经皮肤黑变病并颅内黑色素瘤1例, objectType=article, longId=191099, objectId=1be91910997e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1be91910997e, replyNumber=0, likeNumber=70, createdTime=2020-12-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1be91910997e, moduleTitle=神经皮肤黑变病并颅内黑色素瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1be91910997e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680644, encodeId=b86716806449f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：色素播散综合征虹膜透照缺陷-病例报道, objectType=article, longId=182981, objectId=c522182981d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c522182981d6, replyNumber=0, likeNumber=162, createdTime=2020-02-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c522182981d6, moduleTitle=NEJM：色素播散综合征虹膜透照缺陷-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c522182981d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680641, encodeId=be0e1680641ea, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=女性 X-连锁网状色素异常症, objectType=article, longId=181472, objectId=46791814e2db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46791814e2db, replyNumber=0, likeNumber=75, createdTime=2020-09-23, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46791814e2db, moduleTitle=女性 X-连锁网状色素异常症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46791814e2db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680638, encodeId=5482168063810, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：色素性角化病-病例报道, objectType=article, longId=180868, objectId=013218086866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=013218086866, replyNumber=0, likeNumber=0, createdTime=2020-01-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=013218086866, moduleTitle=NEJM：色素性角化病-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=013218086866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680657, encodeId=5c79168065e84, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性, objectType=article, longId=187698, objectId=727018e69811, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=727018e69811, replyNumber=0, likeNumber=65, createdTime=2020-12-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=727018e69811, moduleTitle=2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727018e69811)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680681, encodeId=9a0a168068147, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=罗氏PD-L1单抗Tecentriq联合靶向疗法：获FDA批准治疗晚期黑色素瘤, objectType=article, longId=198563, objectId=ec5d198563ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec5d198563ab, replyNumber=0, likeNumber=89, createdTime=2021-01-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec5d198563ab, moduleTitle=罗氏PD-L1单抗Tecentriq联合靶向疗法：获FDA批准治疗晚期黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec5d198563ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680645, encodeId=334916806459e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Opdivo与Yervoy的联合未能在晚期黑色素瘤研究中达到所有主要终点, objectType=article, longId=183345, objectId=0b1c18334534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b1c18334534, replyNumber=0, likeNumber=64, createdTime=2020-07-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b1c18334534, moduleTitle=Opdivo与Yervoy的联合未能在晚期黑色素瘤研究中达到所有主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b1c18334534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680639, encodeId=ead3168063952, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=FDA批准了**种增加红细胞生成性原卟啉病患者无痛光照的黑色素生成药Scenesse, objectType=article, longId=181141, objectId=04d9181141bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04d9181141bf, replyNumber=0, likeNumber=65, createdTime=2020-06-30, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04d9181141bf, moduleTitle=FDA批准了**种增加红细胞生成性原卟啉病患者无痛光照的黑色素生成药Scenesse, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04d9181141bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

JCO：CheckMate 066试验| 纳武单抗治疗晚期黑色素瘤的5年随访结果

2020-11-05

sunylz (审核中...)

前往app查看评论内容

#色素#

Clinica Chimica Acta：色素试纸:一种排除蛛网膜下腔出血的快速试验

2021-04-09

sunylz (审核中...)

前往app查看评论内容

#色素#

肺原发黑色素瘤一例

2021-04-08

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：粘膜和手指黑色素瘤转移-病例报道

2021-01-03

sunylz (审核中...)

前往app查看评论内容

#色素#

人各有“痣”：痣出现这些变化，有恶变的可能！黑色素瘤不能小看

2021-07-17

sunylz (审核中...)

前往app查看评论内容

#色素#

腹透液检查竟发现恶性黑色素瘤细胞！

2020-07-11

sunylz (审核中...)

前往app查看评论内容

#色素#

罗氏的PD-L1单抗Tecentriq组合显着降低黑色素瘤患者的疾病进展和死亡风险

2020-05-22

sunylz (审核中...)

前往app查看评论内容

#色素#

ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变

2021-04-28

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Death Dis：HopQ通过降解波形蛋白抑制黑色素瘤迁移

2020-09-30

sunylz (审核中...)

前往app查看评论内容

#色素#

AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）

2021-01-20

sunylz (审核中...)

前往app查看评论内容

#色素#

针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道

2020-09-19

sunylz (审核中...)

前往app查看评论内容

#色素#

色素性单纯性汗腺棘皮瘤1例

2020-10-09

sunylz (审核中...)

前往app查看评论内容

#色素#

神经皮肤黑变病并颅内黑色素瘤1例

2020-12-31

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：色素播散综合征虹膜透照缺陷-病例报道

2020-02-01

sunylz (审核中...)

前往app查看评论内容

#色素#

女性 X-连锁网状色素异常症

2020-09-23

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：色素性角化病-病例报道

2020-01-31

sunylz (审核中...)

前往app查看评论内容

#色素#

2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性

2020-12-03

sunylz (审核中...)

前往app查看评论内容

#色素#

罗氏PD-L1单抗Tecentriq联合靶向疗法：获FDA批准治疗晚期黑色素瘤

2021-01-10

sunylz (审核中...)

前往app查看评论内容

#色素#

Opdivo与Yervoy的联合未能在晚期黑色素瘤研究中达到所有主要终点

2020-07-16

sunylz (审核中...)

前往app查看评论内容

#色素#

FDA批准了**种增加红细胞生成性原卟啉病患者无痛光照的黑色素生成药Scenesse

2020-06-30

科室
- - 订阅+
  - 更多科室
工具
服务